Xiaoyang Wu Selected Research

Xiaoyang Wu Research Topics

Disease

10	Neoplasms (Cancer) 11/2023 - 02/2012
6	Wounds and Injuries (Trauma) 01/2023 - 09/2017
5	Fabry Disease (Fabry's Disease) 09/2019 - 08/2011
3	Acute Lung Injury 12/2024 - 01/2023
3	Inflammation (Inflammations) 10/2023 - 10/2017
2	Stomach Neoplasms (Stomach Cancer) 07/2023 - 02/2012
2	Seizures (Absence Seizure) 01/2023 - 01/2018
2	Infections 01/2023 - 04/2010
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2022 - 08/2019
2	Urinary Retention 10/2022 - 01/2022
2	Cognitive Dysfunction 01/2017 - 12/2016
2	Breast Neoplasms (Breast Cancer) 10/2016 - 08/2005
1	Sepsis (Septicemia) 12/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023
1	Colitis 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 04/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2023
1	Tissue Adhesions 02/2023
1	Epilepsy (Aura) 01/2023
1	Hyperglycemia 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Fatigue 02/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Delirium 01/2022
1	Emphysema 01/2022
1	Stroke (Strokes) 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Cocaine-Related Disorders (Cocaine Addiction) 02/2019
1	Edema (Dropsy) 01/2019
1	Anthrax 01/2019
1	Fetal Alcohol Spectrum Disorders 01/2018
1	Neurodevelopmental Disorders 01/2018
1	Adenocarcinoma of Lung 10/2017
1	Lung Neoplasms (Lung Cancer) 10/2017
1	Weight Gain 01/2017

Drug/Important Bio-Agent (IBA)

4	EndotoxinsIBA 12/2024 - 01/2022
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2004
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 02/2014
4	GalactosidasesIBA 01/2018 - 08/2011
4	CopperIBA 10/2016 - 10/2015
3	HydrogelsIBA 04/2023 - 01/2023
2	Sirtuin 1IBA 12/2024 - 10/2017
2	Long Noncoding RNAIBA 11/2023 - 04/2023
2	InflammasomesIBA 08/2023 - 01/2023
2	Pattern Recognition ReceptorsIBA 11/2022 - 08/2019
2	Adenosine Triphosphate (ATP)IBA 10/2022 - 01/2022
2	Cocaine (Cocaine HCl)IBA 01/2021 - 02/2019
2	migalastatIBA 09/2019 - 01/2017
2	globotriaosylceramide (globotriosylceramide)IBA 01/2018 - 02/2014
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 01/2018
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2017 - 12/2016
2	ProdrugsIBA 10/2016 - 10/2015
2	Human Serum Albumin FDA LinkGeneric 10/2016 - 10/2015
1	Nicotinamide MononucleotideIBA 12/2024
1	Immunologic Factors (Immunomodulators)IBA 10/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 10/2023
1	Fingolimod Hydrochloride (FTY720)FDA Link 10/2023
1	Tryptophan (L-Tryptophan)FDA Link 08/2023
1	5-methoxytryptophanIBA 08/2023
1	RNA (Ribonucleic Acid)IBA 04/2023
1	Hyaluronic Acid (Hyaluronan)IBA 04/2023
1	Urea (Carbamide)FDA LinkGeneric 02/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	carbopol 940 (sodium polyacrylate)IBA 01/2023
1	polyacrylamideIBA 01/2023
1	poly-N-isopropylacrylamideIBA 01/2023
1	AntioxidantsIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	PolymersIBA 01/2023
1	SilverIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Heme Oxygenase-1IBA 01/2023
1	Fibrinogen (Factor I)FDA Link 02/2022
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2022
1	SmokeIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Capsules (Microcapsules)IBA 01/2021
1	ExotoxinsIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	anthrax toxin (anthrax lethal factor)IBA 01/2019
1	ThiosemicarbazonesIBA 01/2018
1	Pentylenetetrazole (Metrazol)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017

Therapy/Procedure

4	Therapeutics 12/2024 - 01/2019
1	Gastrectomy 07/2023
1	Hyperthermic Intraperitoneal Chemotherapy 04/2023
1	Deep Brain Stimulation 01/2023
1	Electroacupuncture 10/2022
1	Catheters 01/2022
1	Laparoscopic Cholecystectomy 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2022
1	Tai Ji (Tai Chi Chuan) 01/2021
1	Rejuvenation 01/2021
1	Skin Transplantation (Skin Grafting) 09/2017